| A.   | Medtech                is the owner                of all Intellectual Property Rights relating to the Product (as defined                in                Clause 1) for the USA, Canada and                certain other countries and                is to be considered the Specification Holder of the                Product; |
|----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| B.   | Pharmaspray                is an                aerosol manufacturer filling aerosol cans with cosmetic and medical                products; |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------|

| C.   | The                Products sold by                Medtech are subject to ISO-13485 Standard and GMP 820                standard; |
|----------------|-----------------------------------------------------------------------------------------------------------------------------------|

| D.   | Pharmaspray                operates                in accordance with ISO-9001:2000                Standard; |
|----------------|--------------------------------------------------------------------------------------------------------------|

| E.   | The                Parties wish to                (co)operate in accordance with ISO-13485 Standard, ISO-9001:2000                Standard,                the Quality Manual (as defined in Clause 1) and the instructions                of                Medtech as specified in the Schedule(s) which form part of this Agreement;                and |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| F.   | The                Parties now wish                to formalize this Agreement as a “Turn-Key Agreement” in which they will                include all their agreements with respect to the Procurement Services,                Production Services, Packaging Services, Logistic Services and other                services provided by Pharmaspray to                Medtech. |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.   | Definitions |
|----------------|-------------|

| 1.1.   | The                term “Acceptance                of the Materials” shall mean the point in time at which the Materials (as                defined hereafter) are physically handed over to or become under                the                control and care of Pharmaspray in order to manufacture and package                the                Products. |
|------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 1.2.   | The                term “Agreement”                shall mean this document including the Quality Manual and all (further)                Schedules and annexes hereto and thereto, each as amended from time                to                time by the Parties upon mutual written                agreement. |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.3.   | The                term                “Commencement Date” shall mean October 5,                2007. |
|------------------|-------------------------------------------------------------------------------------------------------------------|

| 1.4.   | The                term "Delivery                of the Products" shall mean the point in time at which the Products                (as                defined hereafter) are delivered to Medtech or the designated agent                or                distributor of Medtech. Unless otherwise specified in writing, Delivery                of                Products shall occur ex works (EXW, incoterms 2000) in                Veendam. |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.5.   | The                Term “Force                Majeure” shall mean those circumstances which are unforeseeable and beyond                the reasonable control of each of the Parties and which prevent the                total                or partial carrying out of any obligation by a party under this Agreement,                such as acts or regulations or decrees of any government (de facto                or de                jure), natural phenomena, such as earthquakes and floods, fires,                riots,                shipwrecks, freight embargoes or other circumstances whether similar                or                dissimilar to those enumerated                above. |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.6.   | The                term                “Intellectual Property Rights” shall mean any and all intellectual                property rights, good will, know-how and other intangibles relating                to the                Product and its packaging including (but not limited to) national                and                international patents, trade name(s) and                trademark(s). |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.7.   | The                term “Logistic                Services” shall mean all services provided by Pharmaspray as from the                beginning of the manufacture of the Product until the physical delivery                of                the Product to Medtech, Medtech's distributors, agents or other                destinations, including the storage and the arranging of                transport. |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.8.   | The                term “Materials”                shall mean all semi fabrics, ingredients, spare parts, and packaging                material necessary to assemble the                Product. |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.9.   | The                term "Mold"                shall mean the mold purchased by Pharmaspray from NPK Products B.V.                on or                about May 1, 2007 for use by Pharmaspray in the manufacture of the                Product. |
|------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.10.   | The                term “Packaging                Services” shall mean the packaging of the Product(s) (as defined                hereafter) by Pharmaspray according                to the                Quality Manual (as defined hereafter) and other specific                instructions of Medtech. |
|-------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.11.   |  The                term                “Procurement Services” shall mean the various acts of identifying,                qualifying, ordering and obtaining via Purchase Orders or other means                those Materials necessary or appropriate to the production of Products                until such Materials are physically delivered to Pharmaspray. In                performing Procurement Services, Pharmaspray shall act for its own                account                and not as agent for Medtech. |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.12.   | The                term “Product”                shall mean a consumer product composed and/or manufactured on behalf                of                Medtech bearing the Compound W Freeze Off® or other trademarks owned by                Medtech and used for the cryogenic treatment of warts, skin tags                or other                lesions in humans, according to Medtech’s specifications as described in                Schedule |
|-------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|              | 1.                                                                                                                                                                                                                                                                                                                                                                                      |
|-------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|              |                                                                                                                                                                                                                                                                                                                                                                                    |
| 1.13.   | The                term “Production                Services” shall mean the manufacture of the Product, including production,                assembly, filling and labelling of the aerosol cans by Pharmaspray                as                instructed by Medtech in accordance with the terms of this Agreement                and                the Quality Manual. |

| 1.14.   | The                term “Purchase                Order” shall mean a written instruction to provide the Procurement                Services, Production Services, Packaging Services and Logistics Services,                which instruction is prepared by Medtech and directed to Pharmaspray                and                includes specific instruction as to the delivery of the                Product. |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.15.   | The                term “Quality                Manual” shall mean the Quality Agreement attached hereto as Schedule 4, as                it may be subsequently amended, revised or replaced upon mutual written                agreement. |
|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.16.   | The                term “Schedule”                shall mean any schedule to this Agreement, including any amendment                thereto. |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.17.   | The                term “Storage                Location” shall mean the warehouse located at Demeterlaan 30 and Cereslaan                9 (9641 ML) Veendam unless otherwise agreed by the Parties in writing. |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.18.   | The                term “Supplier”                shall mean suppliers designated or appointed by Pharmaspray, subject                to                approval by Medtech, as described – non limitative – in Schedule                2. |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.19.   | The                term “Turn-Key                Agreement” shall mean an understanding between the Parties acknowledging                the assumption of all responsibility by Pharmaspray for                all  Procurement Services, Production Services, Packaging                Services, Logistics Services and other services necessary or appropriate                to the fulfilment of Purchase Orders for the Product except as otherwise                provided in this Agreement. |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | In                as far as                applicable in the context of the Agreement, terms defined in the                singular                shall include the plural and vice versa. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.   | Procurement,                Production, Packaging and Logistic                Services |
|----------------|----------------------------------------------------------------------------------------|

| 2.1.   | On                the terms and                conditions of the Agreement, Medtech hereby appoints Pharmaspray                and                Pharmaspray hereby accepts such appointment to provide the Procurement                Services, Production Services, Packaging Services and the Logistic                Services during the term of the Agreement in a manner befitting a                careful                contractor, excepting only as provided                herein. |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.2.   | Without                limiting the                (general) obligations of the contracting Parties under this Agreement,                the                Parties shall provide mutual assistance and shall co-operate with                each                other and with third parties in order to ensure that the quality                of the                Procurement, Production, Packaging and Logistics Services are maintained                and that the Parties' expectations in entering into this Agreement                are                fulfilled; in particular, Pharmaspray represents that it has such                resources necessary to fulfil its obligations and that it shall be                pro-active in resolving any problems. Medtech shall |
|------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | promptly                inform Pharmaspray of all changes in its Compound W Freeze                Off® business which may impact on the performance of  the Production                Services under this                Agreement. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.3.   | Pharmaspray                shall                provide the Procurement services, Production Services, Packaging                Services                and Logistics Services in accordance with the applicable ISO standards,                the Quality Manual and Schedules, any (other) specific instructions                of                Medtech and any further mandatory national and international                specifications, as applicable from time to                time. |

| 2.4.   | Medtech                will provide                Pharmaspray every month with a twelve month rolling sales forecast                for the                Products. The forecast for the three month period immediately following                the issuance of the forecast shall be converted into Purchase Orders                from                Medtech to Pharmaspray, which Purchase Orders shall be deemed                binding. |
|------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.5.   | If                Pharmaspray                incurs costs directly based upon Medtech’s forecast for the next three                months, and Medtech does not issue a Purchase Order related to those                costs                within six months after the applicable month, Pharmaspray may charge                such                costs to Medtech. |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.6.   | Pharmaspray                will                source the Materials mentioned in Schedule 2 from Suppliers approved                by                Medtech. Pharmaspray will manage a minimum amount of safety stock,                with                the minimum amount to be determined by the Parties.  To the                extent any safety stock agreed by the Parties and maintained by                Pharmaspray becomes obsolete due solely to the actions of Medtech,                Medtech                shall be obligated to reimburse Pharmaspray for its actual cost to                purchase such safety stock. |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.7.   | Pharmaspray                is                responsible for the delivery of the Materials required for the manufacture                or production of the Product to Pharmaspray’s                premises. |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.8.   | Subject                to clause                7.3 and 7.5 and the provisions of Section 9, Pharmaspray is responsible                for the compliance of the Materials with the applicable ISO standards                and                any further national and international specifications applicable                from time                to time at the moment of Acceptance of the Materials. Pharmaspray                shall                check such compliance, in as far as visually observable, at the Acceptance                of the Materials. |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.9.   | Pharmaspray                shall                deliver the Products related to a specific written order of Medtech                to the                distributors or agents of Medtech within four (4) weeks upon such                order,                provided that Pharmaspray has received the sales forecast the specific                order is based upon, in due time. |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.10.   | Medtech                is allowed                to conduct regularly scheduled quality audits of both the production                process and the Product at Pharmaspray’s premises at any reasonable time                after receipt of written notice from Medtech of its intent in advance.                Pharmaspray may require its representative to be present and that                such                visit is under the condition that the internal rules of Pharmaspray                or the                Storage Location are being complied with. Medtech will be responsible                for                all associated costs of such quality audits. Medtech shall have the                right                to reject Products that do not meet the Product Specifications set                forth                in Schedule 1, the Quality Manual or other specific instructions                of                Medtech. Reasonable efforts will be made to salvage usable portions                of any                batch should a sampling of Products not be in compliance with the                Product |
|-------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|              | Specifications              set              forth in Schedule 1, the Quality Manual or other specific instructions              of              Medtech.                 |
|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|              |                                                                                                                                                                      |
| 2.11.   | Pharmaspray                shall                provide Medtech with updates on its business operations as specified                in                the Quality Manual. |

| 2.12.   | Pharmaspray                shall                keep an adequate administration of deliveries to Medtech’s distributors or                agents. Pharmaspray shall provide copies of all shipping documents                to                Medtech in case of re-calls, whatever the cause for such re-calls                may                be. |
|-------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.13.   | Each                Party shall,                upon execution of this Agreement, appoint one of its employees to                be a                relationship manager responsible for liaison between the                Parties.  The relationship managers shall conference not less                than quarterly and meet in person not less than annually to coordinate                the                production activities, handle purchase orders, track assembly progress                and                any packaging work, movement of Product, deliveries, sales status                and the                current status of the business relationship and manage issues that                have                arisen. |
|-------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.14.   | Conveyance                and                delivery of the Products shall occur ex works (EXW) in Veendam, unless                otherwise agreed between the Parties in                writing. |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.15.   | Medtech                is and shall                at all times remain the owner of the Intellectual Property Rights                to the                Product in the United States, Canada and certain other countries                where it                owns Intellectual Property Rights. No license of whatever nature                in                relation to any Intellectual Property Rights is granted by Medtech                to                Pharmaspray.  Pharmaspray shall have the obligation to obtain                and maintain all governmental licenses, permits or approvals necessary                to                manufacture the Product at its facility in                Veendam. |
|-------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.   | Packaging |
|----------------|-----------|

| 3.1.   | Pharmaspray                will                package the Product according to the Quality Manual and other specific                instructions of Medtech. |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.2.   | Pharmaspray                has                acquired the Mold as described in clause 1.9 above. The acquirement                costs                were and will be borne by                Pharmaspray. |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.   | Transport |
|----------------|-----------|

| 4.1.   | Medtech                is                responsible for transport of delivered Products from the premises                of                Pharmaspray at Veendam to her distributors, agents or (other) final                destinations. The Parties agree that Pharmaspray shall organize this                transport under the authority of and on expense of Medtech, thus                acting as                representative of Medtech. |
|------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.2.   | Medtech                shall                designate the carrier(s)/transporter(s) to be involved in transportation                of delivered Products. Pharmaspray, as representative of Medtech,                will                contract these carriers/transporters; Medtech being the contractant                of the                carrier/transporter. |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 4.3.   | All                costs of                transport taking place after delivery, charged to Pharmaspray, will                be                charged on to Medtech. Pharmaspray will provide Medtech with copies                of the                transport invoices the on-charging is based                upon. |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.4.   | After                delivery (ex                works) of the Products has taken place, Pharmaspray is neither responsible                nor liable for the acts and omissions of carriers/transporters that                are                contracted by Pharmaspray on behalf of Medtech. |
|------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|             |                                                                                                                                                                                                                                                                                             |
|             | Loading,              stowage and              discharging                                                                                                                                                                                                                                       |

| 4.5.   | The                obligation of                (un)loading, stowage and discharging the Materials and/or the Products                and                the liability for any damage to and/or loss of the Materials and/or                Products caused by (un)loading, stowage and/or discharging the Materials                and/or the Products rests with Pharmaspray, until delivery of the                Products                to Medtech defined in clause 2.14. |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.6.   | Any                stipulation,                condition, reservation or exemption as to responsibility and/or liability                of Pharmaspray for loss of and/or damage to the Materials and/or                the                Products, occurring during loading on, stowing, and subsequently                to the                discharging from the means of carriage in which the Materials and/or                the                Products are (to be) carried (before delivery to Medtech), shall                be null                and void unless with prior written consent of                Medtech. |
|------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.7.   | Pharmaspray                shall at                all times load, stow and discharge the Materials and the Products                in                accordance with the applicable provisions of the Quality Manual and                the                specific instructions of Medtech. |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.   | Independent                and other Subcontractors of                Pharmaspray |
|----------------|-----------------------------------------------------------------------------------|

| 5.1.   | Pharmaspray                is                entitled to contract and instruct (independent) subcontractors and/or                auxiliary persons for the manufacturing, packaging, and storage of                the                Product, subject to the reasonable written consent of Medtech and                subject                to reasonable assurance that all confidential and proprietary information                of Medtech will be safeguarded. |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.2.   | Pharmaspray                shall be                responsible and liable for the acts and omissions of its employees,                servants, (independent) subcontractors, agents, suppliers and other                persons whose services it uses for the performance of its obligations                under this Agreement, as if such acts and omissions were its own,                cases of                Force Majeure excepted. |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6.   | Rates,                Charges and Payment Terms |
|----------------|-------------------------------------------------|

| 6.1.   | All                rates, costs and                expenses with respect to the production and packaging and storage                services                shall be charged and invoiced by Pharmaspray to Medtech on a weekly                basis                and in conformity with the provisions set down in Schedule 3 regarding                the                rates and charges. The prices set out on Schedule 3 shall be fixed                prices                for the term of this Agreement; provided, however, Pharmaspray shall                be                entitled to pass on to Medtech in the first quarter of each calendar                year,                by mutual written agreement, any significant net increase in prices                charged by third parties in connection with Pharmaspray's services                provided (including any increase in prices |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | for                raw                materials).  In the event of a demonstrable price-increase of                one or more Materials exceeding  5%, Pharmaspray shall also during                the  calendar year be entitled to pass on to Medtech this                price-increase in consultation with                Medtech. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6.2.   | Invoices                shall be                issued and expressed in Euros and payment shall be made in Euros                to a                Dutch bank account of Pharmaspray. If, at the request of Pharmaspray,                any                costs, duties and the like involved with payment shall be paid by                Medtech                in another currency and/or a foreign bank account, the costs for                such                payment shall be borne by                Pharmaspray. |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6.3.   | Any                objections to                the invoice Medtech has received from Pharmaspray shall be made by                Medtech                in writing within sixty (60) days from the invoice date. If no objections                are made within 60 days from the invoice date, the invoice shall                be                binding on both Parties. |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6.4.   | Medtech                shall pay                the invoiced amounts within sixty (60) days counting from the invoice                date. Medtech shall only be allowed to pay at a later date with prior                written consent of Pharmaspray.  If Medtech pays the invoice                within eight (8) days of the invoice date, Medtech shall be entitled                to                receive a credit equal to 3% of the total amount of the invoice,                except of                the costs of transport organized on behalf of Medtech as mentioned                in                clause 4.3 |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6.5.   | Any                payment to be                made by either Party under this Agreement shall be made in                full without set-off, restriction, condition or deduction for or on                account in any counterclaim. |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6.6.   | Any                and all                outstanding payments of Medtech due to Pharmaspray shall become                immediately payable (opeisbaar)                if Medtech is declared bankrupt or in moratorium of payments, discontinues                its business or if its business is                liquidated. |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6.7.   | If                Medtech does not                pay the amount due within the agreed time, Medtech shall be legally                held                to be in default and shall be liable to pay interest equal to the                Dutch                statutory interest rate plus 4% over the entire invoice amount, commencing                on the due date of the invoice, until the actual date of payment.                Medtech                is liable to pay any and all judicial and/or extra-judicial costs                for debt                collection by Pharmaspray. |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6.8.   | To                the extent that                Product produced and delivered by Pharmaspray are for sale and use                in the                United States, Canada or anywhere else outside The Netherlands, no                VAT tax                shall be included in the invoice. |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6.9.   | The                Parties agree                that the prices, rates and charges appearing in Schedule 3 have been                established for purposes of this Agreement with mutual implicit                assumptions in cost of goods sold (“COGS”) and exchange rates between the                U.S. dollar and the Euro. To the extent that fluctuations in exchange                rates occur such that there is a variance of more than 10% in any                twelve                month period in the effective exchange rate, the Parties agree to                meet and                to negotiate in good faith to achieve an equitable and commercially                viable                accommodation. Increases in COGS not primarily related to exchange                rates                shall be subject to annual review, and to the extent reasonably applicable                shall be modulated by published cost-of-living                indexes. |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 7.   | Warranties |
|----------------|------------|

| 7.1.   | Subject                to clause                7.3 and 7.5, Pharmaspray represents and warrants that the performance                of                the Production Services shall be in compliance with the Product                Specifications set forth in Schedule 1, the Quality Manual and any                other                provisions of this Agreement, cases of Force Majeure                excepted. |
|------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7.2.   | Subject                to clauses                7.3, Pharmaspray represents and warrants that she shall assemble                the                Products in complete and correct state and in compliance with the                Product                Specifications set forth in Schedule 1, the Quality Manual and any                other                provisions of this Agreement, cases of Force Majeure                excepted. |
|------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7.3.   | The                representation                and warranty mentioned in clause 7.1 and 7.2 do not apply to defects                in                the Product caused by defects in Materials delivered to Pharmaspray                by  Suppliers if the Materials are accompanied by a certificate                of analysis conforming with the Specifications and all approval procedures                and criteria required by the Quality Manual are met. The representation                and warranty does not apply to texts/artwork edited or provided by                Medtech. |
|------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7.4.   | The                Parties                represent and warrant that, during this Agreement and after termination                and completion of this Agreement, except as may be required by judicial                process or the regulatory requirements of governmental authority                having                jurisdiction over the Parties and/or Products, they shall keep                confidential any information whatsoever regarding the Materials,                the                Products, the contents of this Agreement, and the Quality Manual                and                Schedules and not provide any third party with such confidential                information unless with prior written consent of the other                Party. |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7.5.   | The                Parties agree                that the existing design of the Product is the responsibility of                Medtech                as specification holder. The responsibility of Pharmaspray is to                insure                that production of the Product is in all respects in conformance                with                specifications and applicable regulatory requirements. The warranties                of                Pharmaspray shall be viewed in all respects as limited by this Section                7.5. |
|------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 8.          | Insurance                                                                                                                                                                                                       |
|----------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                     |                                                                                                                                                                                                            |
| 8.1                                            | Both                Parties shall                on request provide the other Party with periodic evidence of satisfactory                product liability insurance coverage for the                Products. |

| 9. | Liability |
|----|-----------|

| 9.1. | Pharmaspray                shall be                liable for any and all damages and costs suffered by Medtech as a                consequence of Pharmaspray's non-performance (“tekortkoming                in de nakoming”) of its obligations under the Agreement, including                but not limited to the warranties granted by Pharmaspray pursuant                to                clause 7.1 and 7.2 of this Agreement, cases of Force Majeure excepted. |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 9.2. | Except                as set forth                in Section 7.5, Pharmaspray shall be responsible for damage, defects,                non-delivery or late delivery caused by Materials from Suppliers.                Notwithstanding the foregoing, Pharmaspray is not liable for damage,                defects, non-delivery or late delivery caused by the design of the                Product, the formula(s), the package or instructions, prescribed                by                Medtech and/or shortcomings caused by Medtech. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 9.3. | As                to arranging for                transport of Products on behalf of Medtech after delivery ex works                has                taken place, Pharmaspray is only liable for her own acts and omissions;                Pharmaspray is not to be considered the insurance carrier or shipper. |
|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 9.4. | The                Parties agree                that Pharmaspray’s liability is in any case limited to the greater of (1)                the invoiced value of the Products for that specific order; or (2)                the                maximum amount Pharmaspray’s insurance company will compensate for in that                particular case provided that Pharmaspray has arranged and maintained                for                sufficient insurance coverage or could reasonably expected to arrange                for,                and maintain a certain level of insurance coverage, considering the                standard practice in the industry, in accordance with this Agreement. |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 9.5. | Only                Medtech shall                be responsible and liable for the content of artwork, consumer                instructions and label copy. Pharmaspray is not responsible or liable                for                the content of consumer instructions, artwork and label copies and                any                (other) texts on the Products, including the Product package. Pharmaspray                shall only be responsible for assuring that only artwork provided                by or                approved by Medtech is accurately utilized. |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 9.6. | Medtech                shall be                liable for any and all material damages and costs suffered by Pharmaspray                as a consequence of a defect (or defects) in Materials delivered                by                Medtech or defect(s) in texts/artwork edited or provided by Medtech. |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 9.7. | Neither                of the                Parties shall be liable in case of Force Majeure. |
|------|------------------------------------------------------------------------------------------------|

| 9.8. | Claims                of either                party against the other expire in accordance with the provisions                of the                Dutch Civil Code. Shorter expiration dates are not valid, unless                with                prior written consent of the other Party. |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 10.    | Indemnifications                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.1.  | Subject                to the                provisions of Sections 7.3, 7.5 and 9, Pharmaspray will hold harmless                and                indemnify Medtech from and in regard to any and all claims by third                parties in connection to the performance by Pharmaspray of the production                and packaging services such as, but not limited to, claims originating                from defectiveness of the Products and/or the Materials required                for the                Products and the production process, cases of Force Majeure excepted. |

| 10.2. | Medtech                will hold                harmless and indemnify Pharmaspray from and in regard to any and                all                claims by third parties other than Suppliers, originating from |
|-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 1. | defects                in the                texts/artwork edited, approved or provided by Medtech, or |
|--------|----|--------------------------------------------------------------------------------------------------------|

----

|   | 2. | the                design of the                Product, formula(s), component parts packaging or instructions provided,                prescribed or designed by Medtech or Medtech’s predecessors in interest. |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 11.  | Exclusivity                                                                                                                                                                                                                                                                                                                      |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|      |                                                                                                                                                                                                                                                                                                                             |
| 11.1.     | During                the term of                this Agreement, Pharmaspray shall not provide any services whatsoever                to                third parties in relation to aerosol products similar to or in any                way                competing with the Product in the United States, Canada and Mexico. |

| 11.2. | During                the term of                this Agreement, Medtech shall purchase the Product only and exclusively                from Pharmaspray. |
|-------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|

| 12.    | Duration              and              Termination                                                                                                                                                                                                                                                                                                                                                                             |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 12.1.  | This                Agreement shall                become effective for an initial period of three years, starting from                the                Commencement Date. This Agreement may be renewed for additional three                year                periods upon the mutual written consent of the Parties no later than                six                months prior to the then applicable expiration date. |

| 12.2. | Each                of the Parties                has the right to terminate this Agreement with immediate effect by                giving                written notice if any of the following events shall occur: |
|-------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | a. | the                other party                breaches any of the terms of this Agreement and fails to remedy such                breach within thirty (30) days after written notice requiring to                do so,                unless such breach or failure does not justify this with its consequences                in view of its minor importance; |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | b. | the                other party                files a petition for moratorium of payments with the competent court                or is                granted a moratorium of payments; |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | c. | the                other party                files a petition for bankruptcy with the competent court or is declared                bankrupt; or |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------|

|   | d. | the                board of                directors of the other party resolves to dissolve or liquidate its                company. |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------|

| 12.3. | In                case of                termination of the Agreement pursuant to Clause 12.2, the terminating                Party is entitled to receive full compensation for any and all direct                damage suffered by it as a result of the termination and/or, in the                case                of the event stated under Clause 12.2 sub a., any damage suffered                as a                result of such breach. |
|-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 12.4. | In                deviation of                Clause 12.1, Medtech may terminate this Agreement with immediate                effect by                giving written notice, without any compensation or damages whatsoever                to                Pharmaspray, if Pharmaspray becomes owned or controlled by or associates                with or merges with a producer who provides production services to                competitors of the Product. |
|-------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.    | Completion              after              termination                                                                                                                                                                                     |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                       |
| 13.1.  | Upon                termination of                the Agreement, Medtech is obliged to take delivery of the Materials                and                (semi) Products still in the possession and/or under the control                of |

----

|   | Pharmaspray              on the              expiration date of the Agreement or, in case of termination with immediate              effect, within 2 weeks upon such termination, after payment of all              outstanding amounts to Pharmaspray. Pharmaspray and Medtech shall mutually              agree as to the allocation of costs incurred for raw materials, labels              and              packaging; provided, that, in the event Medtech terminates this Agreement              for any reason other than as set forth in Sections 12.2 and 12.4 hereof,              Medtech shall be obligated to purchase from Pharmaspray, at Pharmaspray’s              actual cost, any safety stock agreed between Medtech and Pharmaspray;              and              provided further, that, notwithstanding the foregoing, any breaching              Party              shall be fully responsible for such costs (including, without limitation,              safety stock maintained by Pharmaspray).  Medtech shall have the              right, but not the obligation, to purchase any finished Products being              held in Pharmaspray’s inventory for which no Purchase Orders have been              submitted. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 13.2.  | If                Medtech                terminates this Agreement prior to purchasing eight million (8,000,000)                units of the Product from Pharmaspray, Medtech shall purchase the                Mold                from Pharmaspray in an amount equal to 250,000 Euros (the purchase                price                for the Mold) multiplied by a fraction the numerator of which is                the                Shortfall Amount (as defined below) and the denominator of which                is                8,000,000. The “Shortfall Amount” shall equal eight million (8,000,000)                units less the number of units of the Product purchased by Medtech                hereunder through the termination date.  Upon Medtech’s                purchasing eight million (8,000,000) units of the Product from                Pharmaspray, Pharmaspray shall promptly transfer title to the Mold                to                Medtech.                                                                                                                                                                                                                                                      |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|   | Should              the Mold be              utilized by Pharmaspray for purposes other than the manufacture of              the              Product hereunder, the acquisition cost of the Mold to Medtech shall              be              reduced proportionately to the additional              use.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

| 14.    | No              Rescission                                                                                                                                                               |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                     |
| 14.1   | The                Parties herewith                expressly waive the right to rescind the Agreement pursuant to Article                265                of Book 6, Dutch Civil Code. |

| 15.    | Miscellaneous                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 15.1.  | Changes                in the Quality Manual. Subject to the written consent of                Pharmaspray which shall not be unreasonably withheld, delayed or                conditioned, Medtech reserves the right to amend or adapt the Quality                Manual and Schedules to changes in the aforementioned regulation                and                legislation and / or to the introduction of new regulations and /                or                legislation regarding the quality requirements of the Product from                time to                time. |

| 15.2. | Successors                and Assignments. This Agreement is binding on and for the benefit                of both Parties and their successors and permitted assignees. Neither                Party may assign (its rights under) this Agreement without the prior                written consent of the other party. Pharmaspray shall have no rights                in                the Materials and / or Products of Medtech and may not and shall                not                attempt to assign any interests, either real or presumed, to the                Materials                and /or (Semi) Products of Medtech. |
|-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 15.3. | Entire                Agreement. This Agreement represents the entire agreement of the                Parties with respect to its subject matter, and supersedes all prior                proposals, agreements, memoranda and / or understandings with respect                to                this Agreement or its subject matter between Medtech and Wartner                USA B.V.                and Pharmaspray B.V. Any future representation, agreement, understanding                or waiver will only be binding if in writing and signed by the Party                sought to be bound. |
|-------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15.4. | Schedules                and Annexes. Each schedule, annex and / or the applicable                provisions of the Quality Manual will become part of and subject                to this                Agreement upon signature and date by both Parties. |
|-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15.5. | Waivers.                Either Party’s failure strictly to enforce any provision of this Agreement                will not be construed as a waiver of that provision or as excusing                the                other Party from future performance. |
|-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15.6. | Notices.                All notices required or permitted under this Agreement shall be in                writing                unless otherwise indicated in this Agreement. The notifying Party                shall                send the written notice to the address of the other Party as shown                at the                beginning of this Agreement and/or any other address as agreed upon                by the                receiving Party. Sent notices will only be effective upon actual                receipt                by the other Party. |
|-------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15.7. | Electronic                Mail. The Parties agree that day-to-day communication can also                be                by electronic mail (e-mail). Sent e-mail messages will only be effective                upon actual receipt by the other Party. Notwithstanding the preceding                passages, any message, notice and /or document relating to modification                and/or which affects the effect of this Agreement shall only have                binding                effect if in writing (not being electronic mail and/or other electronic                documents) and with written consent of the Parties. |
|-------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15.8. | Confidentiality.                Each Party shall, during this Agreement and after termination and                completion of this Agreement, keep confidential any information whatsoever                regarding the business of the other Party and not provide any third                party                with such confidential information unless with prior written consent                of                the other Party, except as may be reasonably required by judicial                process                or compliance with applicable governmental and regulatory requirements. |
|-------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15.9. | Mandatory                Law. This Agreement shall only take effect to the extent that                its                provisions are not contrary to any provision of mandatory (national                and /                or international) law. Any provision of this Agreement being contrary                to                any provision of mandatory law or otherwise being null and void does                not                effect the validity of the other provisions of this Agreement. |
|-------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15.10. | General                Terms and Conditions. The applicability of any general terms and                conditions of the contracting Parties, other than those which are                expressly and with written consent of both Parties declared applicable                to                the relationship between Medtech and Pharmaspray under this Agreement,                is                hereby expressly excluded. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15.11. | Changes                to the Agreement. Provisions that deviate from this Agreement can                be invoked by both Parties only if and to the extent that these provisions                are accepted by both Parties in writing. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 15.12. | Severability.                If any term or condition of this Agreement is null and void or will                become                null and void during the course of this Agreement, the validity and                effectiveness of all other terms and conditions shall not be impaired                thereby. All terms and conditions of this Agreement are separable. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 16.    | Applicable              law and              jurisdiction                                                                                                                                                                                                                                                       |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                                                            |
| 16.1.  | This                Agreement is                exclusively governed and construed by Dutch law, as will all disputes                that                may arise from this Agreement. All legal concepts to which reference                is                made in this Agreement are Dutch legal concepts. |

|   | All                disputes,                arising in connection with the present Agreement or further contracts                and                / or agreements resulting here from, which cannot be settled amicably,                shall be settled by the competent Court of Groningen, The Netherlands,                notwithstanding higher appeals. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | /s/              Peter J.              Anderson |   | /s/              Jos              Schott |   |   |
|--------|-------------------------------------------------|--------|------------------------------------------|--------|--------|
|   | Medtech              Products Inc.              |   | Pharmaspray              B.V.            |   |   |
|   | By:  Peter              J. Anderson   |   | By:              Jos Schott              |   |   |
|   | Treasurer                                       |   | Managing              Director           |   |   |

----

|      |
|-----------|
| Schedules |

| Schedule              1       | Product              Definitions and Specification |
|-------------------------------|----------------------------------------------------|
| Schedule              2  | Suppliers              and Materials               |
| Schedule              3  | Prices,              Rates and Charges             |
| Schedule              4       | Quality              Manual                        |